¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"colloid carcinoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • carcinoma in situ
    Á¦ÀÚ¸®¾ÏÁ¾
  • corpus carcinoma
    ÀڱøöÅë¾ÏÁ¾, ÀÚ±ÃüºÎ¾ÏÁ¾
  • duct carcinoma
    °ü¾ÏÁ¾
  • duct cell carcinoma
    °ü¼¼Æ÷¾ÏÁ¾
  • eccrine carcinoma
    ¿¡Å©¸°¾ÏÁ¾
  • embryonal carcinoma
    ¹è¾Æ¾ÏÁ¾
  • epidermoid carcinoma
    Ç¥ÇǸð¾ç¾ÏÁ¾
  • follicular carcinoma
    °©»ó»ù¼ÒÆ÷¾ÏÁ¾, ¼ÒÆ÷¾ÏÁ¾
  • giant cell carcinoma
    °Å´ë¼¼Æ÷¾ÏÁ¾
  • glandular carcinoma
    »ù¾ÏÁ¾, ¼±¾ÏÁ¾
  • granulosa cell carcinoma
    °ú¸³¼¼Æ÷¾ÏÁ¾
  • hepatocellular carcinoma
    °£¼¼Æ÷¾ÏÁ¾
  • invasive carcinoma
    ħ½À¾ÏÁ¾
  • islet cell carcinoma
    ¼¶¼¼Æ÷¾ÏÁ¾
  • inflammatory carcinoma
    ¿°ÁõÇü¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • carcinoma in situ
    »óÇdz»¾ÏÁ¾
  • clear cell carcinoma
    Åõ¸í¼¼Æ÷¾ÏÁ¾
  • comedo carcinoma
    (¢¡comedocarcinoma) ¸éÆ÷¾ÏÁ¾
  • corpus carcinoma
    ÀڱøöÅë¾ÏÁ¾, ÀÚ±ÃüºÎ¾ÏÁ¾
  • duct carcinoma
    °ü¾ÏÁ¾
  • duct cell carcinoma
    °ü¼¼Æ÷¾ÏÁ¾
  • eccrine carcinoma
    ¿¡Å©¸°¶¡»ù¾ÏÁ¾
  • embryonal carcinoma
    ¹è¾Æ¾ÏÁ¾
  • epidermoid carcinoma
    (¢¡squamous cell) ÆíÆò¼¼Æ÷¾ÏÁ¾
  • follicular carcinoma
    °©»ó»ù¼ÒÆ÷¾ÏÁ¾, ¼ÒÆ÷¾ÏÁ¾
  • giant cell carcinoma
    °Å´ë¼¼Æ÷¾ÏÁ¾
  • glandular carcinoma
    (¢¡adenocarcinoma) »ù¾ÏÁ¾
  • granulosa cell carcinoma
    °ú¸³¼¼Æ÷¾ÏÁ¾
  • hepatocellular carcinoma
    °£¼¼Æ÷¾ÏÁ¾
  • inflammatory carcinoma
    ¿°Áõ¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pigmented basal cell carcinoma
    »ö¼ÒÄ§Âø ±âÀú¼¼Æ÷¾Ï
  • pilomatrix carcinoma
    ¸ð¹ß±âÁú ¾Ï(Á¾)
  • postcricoid carcinoma
    ÈÄÀ±(»ó)¾ÏÁ¾
  • primary bronchogenic carcinoma
    ¿ø¹ß(¼º)±â°üÁö¾Ï
  • primary carcinoma
    ¿ø¹ß¾ÏÁ¾(ê«Û¡äßðþ)
  • primary cutaneous adenocystic carcinoma
    ¿ø¹ß¼º ÇǺΠ¼±³¶Á¾¼º¾Ï
  • primary hepatic carcinoma
    ¿ø¹ß(¼º) °£¾ÏÁ¾(ê«Û¡(àõ) ÊÜäßðþ)
  • prostate carcinoma
    Àü¸³¼±¾ÏÁ¾(îñí¡àÍäßðþ)
  • prostate,grading of prostate carcinoma
    Àü¸³¼±¼±¾ÏÁ¾µî±Þ(îñí¡àÍàÍäßðþÔõÐä)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • molecular colloid
    ºÐÀÚ(ÝÂí­)ÄÝ·ÎÀ̵å.
  • nodular colloid degeneration
    °áÀý¼º±³Áú º¯¼º
  • positive colloid
    ¾ç¼ºÄÝ·ÎÀ̵å, Á¤(ïá)ÄÝ·ÎÀ̵å.
  • protective colloid
    º¸È£±³Áú.
  • pseudo-colloid milium
    °¡¼º ºñ¸³Á¾
  • reversible colloid
    °¡¿ª(ʦæ½)ÄÝ·ÎÀ̵å.
  • thyroid colloid
    °©»ó¼±ÄÝ·ÎÀ̵å.
  • acinar carcinoma
    ¼±¹æ¾ÏÁ¾(¼±¹æ¾ÏÁ¾).
  • acinic cell carcinoma
    ¼±¹æ¼¼Æ÷¾ÏÁ¾(¡­á¬øàäßðþ)
  • adamantinoid basal cell carcinoma
    ¹ý¶û Á¾¾ç(ÛöÕË ðþåÆ) ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
  • adenocystic carcinoma
    ¼±³¶Á¾¼º¾Ï
  • adenoid basal cell carcinoma
    ¼±»ó(àÍßÒ) ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
  • adenoid cystic carcinoma
    ¼±¾ç³¶¼º¾ÏÁ¾(àÍåÆÒ¥àõäßðþ)
  • adenoid squamous cell carcinoma
    ¼±»ó ÆíÆò »óÇǼ¼Æ÷(àÍßÒ ø·øÁ ß¾ù«á¬øà) ¾Ï
  • adenoma-carcinoma sequence
    ¼±Á¾-¾ÏÁ¾ ¿¬¼â(àÍðþ-äßðþ ææáð)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BCC Basal Cell Carcinoma
Ca   1) Carcinoma
  2) Cancer; ¾Ï
  3) Calcium
CIS Carcinoma In Situ
FMTC Familial Medullary Thyroid Carcinoma
MTC Medullary Thyroid Carcinoma
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BCC Basal Cell Carcinoma
BSC Basaloid Squamous Carcinoma
BSCC Basaloid squamous cell carcinoma
BOSCC Bovine ocular squamous cell carcinoma
BAC Bronchiolo-alveolar carcinoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • carcinoma erysipelatodes
    ´Üµ¶¾ç ¾ÏÁ¾
  • carcinoma in situ
    »óÇdz» ¾ÏÁ¾, µ¿¼Ò³» ¾ÏÁ¾, ÀνÃÅõ ¾ÏÁ¾
    ÇÇºÎ¿Í Á¡¸·À» ÀÌȯÇÏ´Â Çü¼º Àå¾Ö¼º »óÇÇ ÁúȯÀ¸·Î¼­ Àü¾Ï º´¼Ò·Î »ý°¢µÇ°í ÀÖ´Ù. °¢È­ ÀÌ»óÁõÀÌ ½ÉÇÏÁö¸¸ ħ¹üÀº µÇÁö ¾ÊÀº »óÅÂÀÌ´Ù.
  • carcinoma of thyroid
    °©»ó¼± ¾Ï
    º´¸®Á¶Á÷ÇÐÀûÀ¸·Î À¯µÎ¼± ¾Ï, ¿©Æ÷¼± ¾Ï, ¼ö¾ç ¾Ï, ¹ÌºÐÈ­ ¾Ï ¹× °©»ó¼± ¿ø¹ßÀÇ ¾Ç¼º ¸²ÇÁÁ¾À¸·Î ³ª´µ¾î Áø´Ù. °©»ó¼± ¾ÏÀº º´¸®Á¶Á÷ÀÇ Çü¿¡µû¶ó¼­ ³ªÅ¸³ª´Â ¸ð¾ç, Ä¡·á ¹æÄ§, ¿¹Èİ¡ µÎµå·¯Áö°Ô ´Ù¸£´Ù. ºÐÈ­ ¾ÏÀº °©»ó¼±°ú ¼Ò¼Ó ¸²ÇÁÀýÀÇ ¹üÀ§°¡ ±¹ÇѵǾî ÀÖ´Â °ÍÀÌ ´ëºÎºÐÀε¥ Æó³ª »ÀÀÇ ÀüÀ̸¦ °¡Á®¿À´Â °Íµµ ÀÖ´Ù. ¹ÌºÐÈ­¾ÏÀº ¹æ»ç¼± Á¶»ç¿Í Ç×¾ÏÁ¦¸¦ »ç¿ëÇÏ°í ¾Ç¼º ¸²ÇÁÁ¾¿¡´Â ¹æ»ç¼± Á¶»ç°¡ È¿°úÀûÀÌ´Ù.
  • carcinoma ossificans
    È­°ñ¼º ¾ÏÁ¾
    °£Áú¿¡ À¯°ñ, °ñ È­»ýÀÌ ÀϾ´Â ¾ÏÁ¾.
  • carcinoma portionis
    Àڱà ÁúºÎ ¾ÏÁ¾
  • carcinoma telangiectaticum
    ¸ð¼¼Ç÷°ü È®À强 ¾Ï, ¸ð¼¼Ç÷°ü È®À强 ¾ÏÁ¾
  • central mucoepidermoid carcinoma
    °ñ³» Á¡¾× Ç¥ÇǾÏ
    »ó, ÇϾǿ¡ Áß½ÉÀûÀ¸·Î ¹ß»ýÇϸç, ¹è¹ß»ý±â¿¡ Ÿ¾×¼± ¼¼Æ÷°¡ À¯ÀԵǾú°Å³ª Ä¡¼º ³¶ÀÇ Á¡¾× ¼¼Æ÷°¡ Á¾¾çÀ¸·Î ÀüȯµÇ¾î »ý±æ ¼ö ÀÖ´Ù.
  • cheek carcinoma
    ÇùºÎ ¾Ï
  • clear cell basal cell carcinoma
    Åõ¸í ¼¼Æ÷ ±âÀú¼¼Æ÷¾Ï
  • colorectal carcinoma
    °áÀå Á÷Àå¾Ï
  • columnar cell carcinoma
    ¿øÁÖ ¼¼Æ÷ ¾ÏÁ¾
  • cutaneous metastatic carcinoma
    ÇǺΠÀüÀÌ ¾Ï, ÇǺΠÀüÀÌ ¾ÏÁ¾
  • duct carcinoma
    °ü ¾ÏÁ¾
  • embryonal carcinoma
    ¹è¾Æ¼º ¾ÏÁ¾
    °íȯ¿¡ »ý±â´Â °°Àº Á¾·ùÀÇ ¾ÏÁ¾º¸´Ù´Â ´ú ÈçÈ÷ ³­¼Ò¿¡ ¹ß»ýÇÏ°í ¾î¸°ÀÌ¿Í ÀþÀº ¿©¼º¿¡ È£¹ßÇÑ´Ù. Á¶Á÷ÇÐÀûÀ¸·Î ¹Ì¼º¼÷ »óÇÇ ¼¼Æ÷µéÀÌ ¹Ì¸¸¼º ¶Ç´Â ¼±»ó ÇüÅ·Π¹è¿­µÈ´Ù. À¶ÇÕ ¼¼Æ÷ ¿µ¾ç¸· °Å´ë ¼¼Æ÷°¡ ´ëºÎºÐ ÃâÇöÇÏ¿© HCG¿¡ ¾ç¼ºÀ̰í Å»ý±â ¾Ï ¼¼Æ÷´Â ¾ËÆÄ ÅÂ¾Æ ´Ü¹é¿¡ ¾ç¼ºÀÌ´Ù.
  • endometrial carcinoma
    Àڱà ³»¸· ¾ÏÁ¾
    ÇϳªÀÇ ±ºÀº Áö¼ÓÀûÀÎ ¿¡½ºÆ®·Î°Õ Àڱذú Àڱ󻸷 °úÇü¼ºÀÇ ¹è°æ¿¡¼­ ¹ß»ýÇÑ´Ù´Â °ÍÀÌ´Ù. Àڱ󻸷 °úÇü¼º°ú ¾ÏÁ¾Àº ºñ¸¸°ú ¹«¹è¶õ ÁÖ±â¿Íµµ À¯°üÇÏ´Ù. ÀÌ·¯ÇÑ ÀÎÀÚµé°ú ¿¬°üµÇ¾î ¹ß»ýÇÑ ³»¸· ¾ÏÀº ºÐÈ­°¡ ÁÁÀº °æÇâÀÌ ÀÖ°í ÇüÅÂÇÐÀûÀ¸·Î Á¤»ó ³»¸·¼±°ú À¯»çÇÑ "Àڱ󻸷¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
unstable colloid A colloid that is not again soluble in water after having been dried at ordinary temperature.
Synonym: unstable colloid.
(05 Mar 2000)
198Au colloid A radioactive isotope of gold emitting negative beta particles and gamma radiation, with a half-life of 2.7 days; formerly used for irradiation of closed serous cavities in the palliative treatment of ascites and pleural effusion due to metastatic malignancies, and for liver scans.
Synonym: 198Au colloid, colloidal radioactive gold.
(05 Mar 2000)
lyophilic colloid A colloidal dispersion in which the dispersed particles are more or less liquid and exert a certain attraction on and absorb a certain quantity of the fluid in which they are suspended.
Synonym: emulsion colloid, hydrophil colloid, hydrophilic colloid, lyophilic colloid.
(05 Mar 2000)
lyophobic colloid A colloidal solution in which the disperse particles are solid and lyophobe or hydrophobe, and are therefore sharply demarcated from the fluid in which they are suspended.
Synonym: hydrophobic colloid, lyophobic colloid, suspension colloid.
Origin: suspension + G. Eidos, resemblance
(05 Mar 2000)
acinar carcinoma <tumour> An adenocarcinoma arising from secreting cells of a racemose gland, particularly the salivary glands.
Synonym: acinar carcinoma, acinic cell carcinoma, acinose carcinoma, acinous carcinoma.
(05 Mar 2000)
acinic cell carcinoma <tumour> An adenocarcinoma arising from secreting cells of a racemose gland, particularly the salivary glands.
Synonym: acinar carcinoma, acinic cell carcinoma, acinose carcinoma, acinous carcinoma.
(05 Mar 2000)
acinous carcinoma <tumour> An adenocarcinoma arising from secreting cells of a racemose gland, particularly the salivary glands.
Synonym: acinar carcinoma, acinic cell carcinoma, acinose carcinoma, acinous carcinoma.
(05 Mar 2000)
adenoid cystic carcinoma <tumour> A histologic type of carcinoma characterised by large epithelial masses containing round, glandlike spaces or cysts which frequently contain mucus or collagen and are bordered by a few or many layers of epithelial cells without intervening stroma, forming a cribriform pattern like a slice of Swiss cheese; perineural invasion and haematogenous metastasis are common; occurs most commonly in salivary glands.
Synonym: cylindromatous carcinoma.
(05 Mar 2000)
adenoid squamous cell carcinoma <tumour> A malignant neoplasm consisting chiefly of glandular epithelium (adenocarcinoma), usually well differentiated, with foci of metaplasia to squamous (or epidermoid) neoplastic cells.
Synonym: adenoid squamous cell carcinoma.
(05 Mar 2000)
adenosquamous carcinoma <tumour> A type of lung tumour exhibiting areas of clear cut glandular and squamous cell differentiation along with regions of the undifferentiated carcinoma.
(05 Mar 2000)
adnexal carcinoma <tumour> A carcinoma arising in, or forming structures resembling, skin appendages.
(05 Mar 2000)
alveolar cell carcinoma <tumour> A carcinoma, thought to be derived from epithelium of terminal bronchioles, in which the neoplastic tissue extends along the alveolar walls and grows in small masses within the alveoli; involvement may be uniformly diffuse and massive, or nodular, or lobular; microscopically, the neoplastic cells are cuboidal or columnar and form papillary structures; mucin may be demonstrated in some of the cells and in the material in the alveoli, which also includes denuded cells; metastases in regional lymph nodes, and even in more distant sites, are known to occur, but are infrequent.
Synonym: alveolar cell carcinoma, bronchiolar adenocarcinoma, bronchiolo-alveolar carcinoma, bronchioloalveolar adenocarcinoma.
(05 Mar 2000)
anaplastic carcinoma <tumour> Carcinoma with absence of epithelial structural differentiation.
(05 Mar 2000)
anaplastic carcinoma of the thyroid <oncology, tumour> An aggressive form and rare form of thyroid cancer that is one of the most rapidly growing and invasive types of thyroid cancer.
It commonly occurs in people over 60 years of age and may cause obstruction of the trachea. The cause is unknown but exposure to radiation may be a factor.
Thyroid function tests are usually normal. Hoarse voice, cough and coughing up blood are common symptoms. Examination may reveal nodules in the thyroid gland.
Diagnosis is made via biopsy. Treatment is surgical with or without radiation therapy.
(27 Sep 1997)
apocrine carcinoma <tumour> A carcinoma composed predominantly of cells with abundant eosinophilic granular cytoplasm, occurring in the breast, a carcinoma of the apocrine glands.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á